2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1063616472 MD
Verify on CMS →

JANE MYUNG, MD

Retina Specialist (Ophthalmology) Physician in LACEY, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
296
Medicare Part D claims · 101 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 558
Generic prescribing
65%
generic claims · 35% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.5435/100
▲ 8 pts above national avg 83.1 · [object Object]
Industry payments
$18.74
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JANE MYUNG, MD reported a CMS MIPS final score of 91.5435/100 — above the 83.1 national average — and filed 296 Medicare Part D claims in 2023.

91.5435/100
MIPS score · +8 vs avg
296
Part D claims, 2023
65%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JANE MYUNG, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

92 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

JANE MYUNG, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JANE MYUNG, MD?

High performer (top quartile)

NPI registry status

Active

Issued 06/12/2007

NPI 1063616472

Primary specialty

Retina Specialist (Ophthalmology) Physician

Niche

913 US NPIs in this specialty

Medicare Part D claims

296 47% vs specialty avg

2023 prescription claims

Specialty avg: 558

MIPS final score

91.5435/100 8.4435% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Washington

How Retina Specialist (Ophthalmology) Physician compares to other specialties among Washington providers

Washington providers

Retina Specialist (Ophthalmology) Physician share within Washington

1. Retina Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Retina Specialist (Ophthalmology) Physician share within Washington

Medicare quality performance — MIPS

JANE MYUNG, MD's 2023 MIPS final score plotted against the Retina Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
91.5435/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Retina Specialist (Ophthalmology) Physician) — 91.5435/100 vs national avg 83.1

0%100%National avg83%91.5%
MIPS final score (Retina Specialist (Ophthalmology) Physician) — 91.5435/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JANE MYUNG, MD appears in the CMS NPPES registry as a Retina Specialist (Ophthalmology) Physician provider holding MD credentials at 345 COLLEGE ST STE C, LACEY, WA, 98503, with a listed phone of (360) 456-3200. NPI 1063616472 was issued on 06/12/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MYUNG most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 296 prescription claims written by this provider, covering 101 Medicare beneficiaries and totaling roughly $15K in drug spend, split 35% brand-name and 65% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.5435/100 for the 2023 performance year (Quality 100, Cost 71.8116), compared with the national average of 83.1.

Retina Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 558 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

345 COLLEGE ST STE C
LACEY, WA 98503

Provider Details

NPI 1063616472
Specialty Retina Specialist (Ophthalmology) Physician
Credentials MD
Gender Female
NPI Issued 06/12/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.5435
Final Score
Avg: 83.1
100
Quality
71.8116
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where JANE MYUNG, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

EYE PHYSICIANS OF OLYMPIA INC PS
LACEY, WA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JANE MYUNG, MD. Source: openpaymentsdata.cms.gov.

Total received

$19

Largest payer

Astellas Pharma US Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to JANE MYUNG, MD. To verify JANE MYUNG, MD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

JANE MYUNG, MD — brand share 35.0%
Specialty average (est.)

35% brand-name claims vs 65% generic, on 296 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

296
Total Claims
$15K
Total Drug Cost
101
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
474
Total Day Supply
13,057
Brand vs Generic
35% brand / 65% generic
Brand Drug Cost
$7K
Generic Drug Cost
$7K

Patient Demographics

Average Patient Age
74.7 years
Avg HCC Risk Score
1.20
Gender Split
61% female / 39% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JANE MYUNG, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisolone Acetate
83
Ofloxacin
59
Timolol Maleate
19
Brimonidine Tartrate
18
Latanoprost
18
Difluprednate
17
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
13
Ketorolac Tromethamine
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Retina Specialist (Ophthalmology) Physician Overview

How JANE MYUNG, MD fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.

913
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
558
Avg Claims per Provider

JANE MYUNG, MD's 296 claims are below the specialty average of 558.

Nearby Retina Specialist (Ophthalmology) Physician Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as MYUNG.

Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JANE MYUNG, MD's specialty?
JANE MYUNG, MD specializes in Retina Specialist (Ophthalmology) Physician and practices in LACEY, Washington. Credentials: MD.
How much does JANE MYUNG, MD prescribe under Medicare Part D?
In 2023, JANE MYUNG, MD wrote 296 Medicare Part D claims totaling $15K in drug costs for 101 beneficiaries.
What is JANE MYUNG, MD's Medicare quality score?
JANE MYUNG, MD has a CMS MIPS Final Score of 91.5435/100 (Quality: 100, Cost: 71.8116). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JANE MYUNG, MD located?
JANE MYUNG, MD is located at 345 COLLEGE ST STE C, LACEY, WA, 98503. Phone: (360) 456-3200.
What is JANE MYUNG, MD's NPI number?
JANE MYUNG, MD's National Provider Identifier (NPI) is 1063616472, issued on 06/12/2007.
Does JANE MYUNG, MD prescribe more brand-name or generic drugs?
JANE MYUNG, MD's prescribing is 35% brand-name and 65% generic drugs by claim count, with $7K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US?
There are 913 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 558 Medicare Part D claims per year.
What drugs does JANE MYUNG, MD prescribe most often?
Based on 2023 Medicare Part D data, JANE MYUNG, MD's most frequently prescribed drugs include Prednisolone Acetate, Ofloxacin, Timolol Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JANE MYUNG, MD accept Medicare?
JANE MYUNG, MD appears in CMS Medicare data with 296 Part D claims and 101 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JANE MYUNG, MD's credentials?
JANE MYUNG, MD's NPI is 1063616472 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology